ClinicalTrials.gg
CompletedNCT05206734Updated Jun 15, 2025Results posted

Risk of Mental Health Conditions in Children and Young Adults With Inflammatory Bowel Disease and Influence on Health

An observational study in Inflammatory Bowel Diseases, Depressive Episode and Recurrent Depressive Disorder, sponsored by Momentum Data. Completed at 1 site in United Kingdom. Open to participants aged 5 Years to 25 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-06-15.

Sponsored by Momentum Data · Observational

Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
19,469
Ages
5 Years to 25 Years
Sex
All
01

Study summary

This study is a large population-based analysis in the United Kingdom (UK) using routine primary care data to investigate the impacts on quality-of-life outcomes and use of healthcare services in people aged 5 - 25 years diagnosed with Inflammatory Bowel Disease (IBD) and the impacts of mental health conditions in those diagnosed with IBD.

Read the detailed description

This study will use routinely electronic medical record (EMR) data from primary care practices within the Optimum Patient Care Research Database (OPCRD).

Stream 1 primary objective is to compare the prevalence and cumulative incidence of mental health conditions in children, adolescents and young adults (aged 5-25 years) with a diagnosis of Inflammatory Bowel Disease (IBD), compared to matched population controls without a diagnosis of IBD. The secondary objective is to determine the severity of mental health outcomes in those with and without a diagnosis of IBD.

Stream 2 primary objective is to determine the impact of mental health conditions in children, adolescents and young adults (aged 5-25 years) diagnosed with IBD on quality-of-life indicators, such as records for absence from work or school, unemployment, sleep disturbance and substance abuse.

The secondary objectives are to compare indicators of IBD severity, such as medication use, surgical intervention, nutritional supplement prescriptions and markers of nutritional status including underweight or growth retardation,and healthcare resource utilisation.These impacts and indicators will be assessed using participants that have been diagnosed with IBD, comparing those with the presence of a mental health condition to those without a mental health condition.

02

Conditions studied

  • Inflammatory Bowel Diseases
  • Depressive Episode
  • Recurrent Depressive Disorder
  • Anxiety Disorder
  • Psychological Disorder
  • Self Harm
  • Suicide, Attempted
  • Parasuicide
  • Eating Disorders
  • Body Image Disorder
  • Attention Deficit Hyperactivity Disorder
  • Behavioral Disorder
  • Adjustment Disorders
  • Acute Stress Disorder
  • Schizophrenia
  • Bipolar Disorder
  • Post-traumatic Stress Disorder
  • Sleep Disturbance
03

In context

Inflammatory Bowel Diseases

1,550 studies on the registry are indexed under Inflammatory Bowel Diseases; 426 are open to participants now.

This study's enrollment of 19,469 is above the median of 140 across 626 observational studies indexed under Inflammatory Bowel Diseases.

Browse Inflammatory Bowel Diseases studies →

Lead sponsor

Momentum Data is the lead sponsor of 11 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
5 Years to 25 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Cases of IBD in childhood and young adults and age, gender and GP matched controls.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Aged between 5 years and 25 years
  • Registration with a general practices (GP) contributing routinely collected electronic healthcare data to the Optimum Patient Care Research Database (OPCRD) for more than 6 months during the follow up period
  • A recorded diagnosis of IBD in the clinical record (cases)

Exclusion criteria

Exclusion Criteria:

  • None
05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
19,469 participants (actual)
Patient registry
No

Groups and cohorts

  • IBD Cases

    All incident cases of Inflammatory Bowel Disease (IBD); comprising of Ulcerative Colitis, Crohn's Disease and IBD Unclassified in children, adolescents and young adults up to their 25th birthday. Cases will be defined based on an algorithm using diagnostic codes from the electronic medical record (EMR).

    Other: No specific intervention

  • Matched Controls

    People without a diagnosis in their electronic medical record (ERM) of Inflammatory Bowel Disease, matched on age group, sex, ethnicity (consistent with UK census categories: White, Asian, Black, Mixed, Other), index of multiple deprivation based on postcode, and by practice where numbers allow.

    Other: No specific intervention

  • IBD cases with mental health condition

    A subset of the IBD cases comprising of those participants with the presence of a mental health condition at the same date as their IBD diagnosis. Mental health defined by the diagnosis of any of depression (recurrent depressive disorder or depressive episode), non-phobia-related anxiety disorder (AD), eating disorders, body image disorder, attention-deficit disorder, behavioural disorders, adjustment disorder, acute stress disorder, schizophrenia, bipolar disorder or post-traumatic stress disorder

    Other: No specific intervention

  • IBD cases without mental health condition

    A subset of the IBD cases comprising of those participants with the absence of a mental health condition at the same date as their IBD diagnosis. Mental health defined by the diagnosis of any of depression (recurrent depressive disorder or depressive episode), non-phobia-related anxiety disorder (AD), eating disorders, body image disorder, attention-deficit disorder, behavioural disorders, adjustment disorder, acute stress disorder, schizophrenia, bipolar disorder or post-traumatic stress disorder

    Other: No specific intervention

Interventions

  • OtherNo specific intervention

    Observational analysis of usual care only.

06

What researchers measure

Primary outcomes

  1. Stream 1: Percentage of Participants Who Developed Any Mental Health Condition

    Cumulative incidence (percentage of participants in each arm who developed any mental health condition) was calculated using Kaplan-Meier analysis

    Time frame: 5 years

  2. Stream 1: Relative Risk of Any Mental Health Condition

    Calculated using Cox proportional hazards models using matched controls as the reference group. Adjusted for age, sex, socioeconomic status, ethnicity, and other common chronic childhood conditions.

    Time frame: Retrospective data assessed from 2010-2020, up to 10 years

  3. Stream 2: Relative Risk of Bowel Symptoms (Quality of Life Indicator)

    Bowel symptoms consist of abdominal pain, bloating, discomfort and diarrhoea. Relative risk in participants with mental health conditions compared with those without mental health (MH) conditions. Calculated using negative binomial regression.

    Time frame: 5 years of follow-up.

  4. Stream 2: Relative Risk of Sleep Disturbance (Quality of Life Indicator)

    Relative risk in participants with mental health conditions compared with those without MH conditions. Calculated using Cox regression.

    Time frame: 5 years of follow-up.

  5. Stream 2: Relative Risk of Low Mood (Emotional Function)

    Relative risk in participants with mental health conditions compared with those without MH conditions. Calculated using negative binomial regression.

    Time frame: 5 years of follow-up.

Secondary outcomes

  1. Stream 1: Lifetime Risk of Developing a Mental Health Condition

    Probability of developing a mental health condition by age 25 years.Estimated using modified Cox regression models

    Time frame: Retrospective data assessed from 2010-2020, up to 10 years

  2. Stream 2: Relative Risk of Increased Primary Care Utilisation

    Relative risk of increased primary care visits in participants with mental health conditions compared with those without MH conditions. Calculated using negative binomial regression.

    Time frame: 5 years of follow-up.

  3. Stream 2: Relative Risk of Increased Hospital Admissions

    Relative risk of increased hospital admissions in participants with mental health conditions compared with those without MH conditions. Calculated using negative binomial regression.

    Time frame: 5 years of follow-up.

07

Results

Posted Jun 15, 2025

Participant flow

Participant flow — Overall Study
MilestoneIBD CasesMatched Controls
Started389815571
Ibd cases with mental health condition2950
Ibd cases without mental health condition16480
Completed389815571
Not completed00

Outcome measures

PrimaryStream 1: Percentage of Participants Who Developed Any Mental Health Condition

Cumulative incidence (percentage of participants in each arm who developed any mental health condition) was calculated using Kaplan-Meier analysis

Time frame:
5 years
Reported as:
Number · percentage of participants
Stream 1: Percentage of Participants Who Developed Any Mental Health Condition
percentage of participantsIBD CasesMatched Controls
Stream 1: Percentage of Participants Who Developed Any Mental Health Condition12.0 (10.5 to 13.4)9.4 (8.7 to 10.1)
PrimaryStream 1: Relative Risk of Any Mental Health Condition

Calculated using Cox proportional hazards models using matched controls as the reference group. Adjusted for age, sex, socioeconomic status, ethnicity, and other common chronic childhood conditions.

Time frame:
Retrospective data assessed from 2010-2020, up to 10 years
Reported as:
Count of participants · Participants
Stream 1: Relative Risk of Any Mental Health Condition
ParticipantsIBD CasesMatched Controls (Reference Group)
Stream 1: Relative Risk of Any Mental Health Condition299811
Statistical analysis
  • Matched Controls (Reference Group) · Hazard ratio (hr): 1.28 · 95% CI 1.12 to 1.46HR was calculated using a Cox Proportional Hazard model adjusted for age,sex,socioeconomic status, ethnicity and common childhood conditions. Reflects a comparison of the incidence rates between participants diagnosed with IBD and those without IBD.
PrimaryStream 2: Relative Risk of Bowel Symptoms (Quality of Life Indicator)

Bowel symptoms consist of abdominal pain, bloating, discomfort and diarrhoea. Relative risk in participants with mental health conditions compared with those without mental health (MH) conditions. Calculated using negative binomial regression.

Time frame:
5 years of follow-up.
Reported as:
Count of participants · Participants
Stream 2: Relative Risk of Bowel Symptoms (Quality of Life Indicator)
ParticipantsIBD Cases With Mental Health ConditionIBD Cases Without Mental Health Condition (Reference Group)
Stream 2: Relative Risk of Bowel Symptoms (Quality of Life Indicator)148473
Statistical analysis
  • IBD Cases Without Mental Health Condition (Reference Group) · Risk ratio (rr): 1.82 · 95% CI 1.33 to 2.52RR calculated using negative binomial model adjusted for age,sex,socioeconomic status,ethnicity,IBD type and comorbidities.Reflects a comparison of the incidence rate ratio between IBD participants diagnosed with and without mental health conditions.
PrimaryStream 2: Relative Risk of Sleep Disturbance (Quality of Life Indicator)

Relative risk in participants with mental health conditions compared with those without MH conditions. Calculated using Cox regression.

Time frame:
5 years of follow-up.
Reported as:
Count of participants · Participants
Stream 2: Relative Risk of Sleep Disturbance (Quality of Life Indicator)
ParticipantsIBD Cases With Mental Health ConditionIBD Cases Without Mental Health Condition (Reference Group)
Stream 2: Relative Risk of Sleep Disturbance (Quality of Life Indicator)2683
Statistical analysis
  • IBD Cases Without Mental Health Condition (Reference Group) · Hazard ratio (hr): 1.63 · 95% CI 1.02 to 2.62HR calculated using Cox regression models adjusted for age,sex,socioeconomic status,ethnicity,IBD type and comorbidities.Reflects a comparison of the incidence rate ratio between IBD participants diagnosed with and without mental health conditions.
PrimaryStream 2: Relative Risk of Low Mood (Emotional Function)

Relative risk in participants with mental health conditions compared with those without MH conditions. Calculated using negative binomial regression.

Time frame:
5 years of follow-up.
Reported as:
Count of participants · Participants
Stream 2: Relative Risk of Low Mood (Emotional Function)
ParticipantsIBD Cases With Mental Health ConditionIBD Cases Without Mental Health Condition (Reference Group)
Stream 2: Relative Risk of Low Mood (Emotional Function)63119
Statistical analysis
  • IBD Cases Without Mental Health Condition (Reference Group) · Risk ratio (rr): 2.78 · 95% CI 1.76 to 4.43RR calculated using negative binomial model adjusted for age,sex,socioeconomic status,ethnicity,IBD type and comorbidities.Reflects a comparison of the incidence rate ratio between IBD participants diagnosed with and without mental health conditions.
SecondaryStream 1: Lifetime Risk of Developing a Mental Health Condition

Probability of developing a mental health condition by age 25 years.Estimated using modified Cox regression models

Time frame:
Retrospective data assessed from 2010-2020, up to 10 years
Reported as:
Number · percentage of participants analyzed
Stream 1: Lifetime Risk of Developing a Mental Health Condition
percentage of participants analyzedIBD CasesMatched Controls
Stream 1: Lifetime Risk of Developing a Mental Health Condition31.125.1
SecondaryStream 2: Relative Risk of Increased Primary Care Utilisation

Relative risk of increased primary care visits in participants with mental health conditions compared with those without MH conditions. Calculated using negative binomial regression.

Time frame:
5 years of follow-up.
Reported as:
Number · Count of prinary care interactions
Stream 2: Relative Risk of Increased Primary Care Utilisation
Count of prinary care interactionsIBD Cases With Mental Health ConditionIBD Cases Without Mental Health Condition (Reference Group)
Stream 2: Relative Risk of Increased Primary Care Utilisation1288158153
Statistical analysis
  • IBD Cases Without Mental Health Condition (Reference Group) · Risk ratio (rr): 1.33 · 95% CI 1.12 to 1.58RR calculated using negative binomial model adjusted for age,sex,socioeconomic status,ethnicity,IBD type and comorbidities.Reflects a comparison of the incidence rate ratio between IBD participants diagnosed with and without mental health conditions.
SecondaryStream 2: Relative Risk of Increased Hospital Admissions

Relative risk of increased hospital admissions in participants with mental health conditions compared with those without MH conditions. Calculated using negative binomial regression.

Time frame:
5 years of follow-up.
Reported as:
Number · Count of general hospital admissions
Stream 2: Relative Risk of Increased Hospital Admissions
Count of general hospital admissionsIBD Cases With Mental Health ConditionIBD Cases Without Mental Health Condition (Reference Group)
Stream 2: Relative Risk of Increased Hospital Admissions3391295
Statistical analysis
  • IBD Cases Without Mental Health Condition (Reference Group) · Risk ratio (rr): 1.87 · 95% CI 1.29 to 2.75RR calculated using negative binomial model adjusted for age,sex,socioeconomic status,ethnicity,IBD type and comorbidities.Reflects a comparison of the incidence rate ratio between IBD participants diagnosed with and without mental health conditions.

Adverse events

Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
People Diagnosed With Inflammatory Bowel Disease and Presence of a Mental Health Condition———
People Diagnosed With Inflammatory Bowel Disease and Absence of a Mental Health Condition———

Baseline characteristics

Age, Continuous
Age, Continuous(years)IBD CasesMatched ControlsTotal
Median19 (15 to 21)19 (15 to 21)19 (15 to 21)
Age, Customized
Age, Customized(Participants)IBD CasesMatched ControlsTotal
Age subgroup — 5-11 years36414661830
Age subgroup — 12-17 years117846845862
Age subgroup — 18-25 years2356942111777
Sex: Female, Male
Sex: Female, Male(Participants)IBD CasesMatched ControlsTotal
Female181972629081
Male2079830910388
Race/Ethnicity, Customized
Race/Ethnicity, Customized(Participants)IBD CasesMatched ControlsTotal
Asian or Asian British27610001276
Black or Black British35176211
White196375369499
Mixed50136186
Not stated183703886
Other173548721
Missing121854726690
Deprivation quintile
Deprivation quintile(Participants)IBD CasesMatched ControlsTotal
1 (most deprived)24310191262
274929733722
3117246235795
4119348116004
5 (least deprived)2098471056
Missing33212981630
08

Study locations

1 site
  • Momentum Data Ltd
    London, WC1X 8QT, United Kingdom
09

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: Yes — OPCRD data can be access by bone fide researchers for specific research projects subject to approval by Anonymised Data Ethics \& Protocol Transparency (ADEPT) Committee. The data used for this study cannot be made available without such approval.

Supporting information: Study protocol

Time frame: The data will be available subject to approval for two years after the study publication date.

Access criteria: Data sharing is subject to ADEPT Committee approval.

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 15, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT05206734
Lead sponsor
Momentum Data
Collaborators
Optimum Patient Care
Responsible party
Sponsor
First posted
Jan 25, 2022
Start date
Jan 5, 2022
Primary completion
Mar 31, 2023
Completion
Aug 15, 2023
Results posted
Jun 15, 2025
Last update
Jun 15, 2025

Study contacts

Andrew McGovern, MD
principal investigator · Momentum Data

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion